Kamel MA

References (5)

Title : Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model - Shehata_2023_Int.J.Nanomedicine_18_4193
Author(s) : Shehata MK , Ismail AA , Kamel MA
Ref : Int J Nanomedicine , 18 :4193 , 2023
Abstract :
PubMedSearch : Shehata_2023_Int.J.Nanomedicine_18_4193
PubMedID: 37534058

Title : Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation - Shehata_2023_Int.J.Nanomedicine_18_1631
Author(s) : Shehata MK , Ismail AA , Kamel MA
Ref : Int J Nanomedicine , 18 :1631 , 2023
Abstract :
PubMedSearch : Shehata_2023_Int.J.Nanomedicine_18_1631
PubMedID: 37020692

Title : Ameliorative effects of astaxanthin on brain tissues of alzheimer's disease-like model: cross talk between neuronal-specific microRNA-124 and related pathways - Hafez_2021_Mol.Cell.Biochem__
Author(s) : Hafez HA , Kamel MA , Osman MY , Osman HM , Elblehi SS , Mahmoud SA
Ref : Molecular & Cellular Biochemistry , : , 2021
Abstract :
PubMedSearch : Hafez_2021_Mol.Cell.Biochem__
PubMedID: 33575874

Title : Galantamine in rheumatoid arthritis: A cross talk of parasympathetic and sympathetic system regulates synovium-derived microRNAs and related pathogenic pathways - Gowayed_2020_Eur.J.Pharmacol__173315
Author(s) : Gowayed MA , Mahmoud SA , Michel TN , Kamel MA , El-Tahan RA
Ref : European Journal of Pharmacology , :173315 , 2020
Abstract :
PubMedSearch : Gowayed_2020_Eur.J.Pharmacol__173315
PubMedID: 32621912

Title : Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug - Ali_2015_PLoS.One_10_e0134648
Author(s) : Ali MA , El-Abhar HS , Kamel MA , Attia AS
Ref : PLoS ONE , 10 :e0134648 , 2015
Abstract :
PubMedSearch : Ali_2015_PLoS.One_10_e0134648
PubMedID: 26262991